DWH - If the Top Line results have any recognition of secondary targets we may actually have action closer to BIIB in mid July for market cap growth when they brought their Alzheimer's trial results out. Somewhere inbetween Amarin and BIIB would be fine by me. We are now less than 3 months from completion of dosing. For as long as a number of people on this board have been involved in this company that's like saying...tomorrow. Just 2 to 3 months after that is the Top Line results, kind of like next week for some. These book ends are closing in so fast now that some could lose something near and dear to them if their not careful.

tada